QualityStocksNewsBreaks Archives - Page 666 of 1517

WednesdaySep 15, 2021 9:29 am

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Releases Q3 2021 Report, Updated Guidance

Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, has released its third-quarter 2021 revenues, which are lower than expected. In the report, the company observed that the U.S. Food and Drug Administration’s (“FDA”) Premarket Tobacco Application (“PMTA”) process has impacted its revenues. The company noted that it believes many retailers and distributors have been reluctant to take on new inventory because they were concerned about being left with inventory that, as a result of the PMTA, would be illegal to sell. The company also noted that other retailers may have purchased counterfeit or suboptimal…

TuesdaySep 14, 2021 3:03 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding Retail, Cultivation Footprint in Florida

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a company leveraging brand acquisitions and partnerships to become one of the top three multistate operators in the U.S. legal cannabis and hemp market, recently completed the acquisition of an operational 45,000-square-foot greenhouse sited on 4.7 acres of land in Apopka, Florida. According to the GM of RWB Florida, Jim Frazier, who is quoted in a recent article, “The Apopka acquisition cements the fact that we are committed to expansion in Florida, which is in line with the overall company’s growth strategy across the country.” The acquisition follows that of the…

TuesdaySep 14, 2021 2:51 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leveraging Partnerships to Save Patients’ Lives, Broaden Product Pipeline

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, recently announced a cooperation agreement with Roche Pharmaceuticals China, a subsidiary of Roche Holdings AG, to explore novel medical solutions. Under the agreement, “both parties plan to utilize AnPac Bio’s Cancer Differentiation Analysis (‘CDA’) cancer detection technology and Roche’s FoundationOne CDx to create a solution that customers with a high cancer risk level as assessed by CDA and later diagnosed with cancer can receive a personalized CDx precision medical test for therapy selection. The parties aim to help benefit the general population while lowering costs…

TuesdaySep 14, 2021 2:35 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Is Frontrunner in Support of Psychedelic-Assisted Therapy

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, is devoted to building access to safe, science- and evidence-backed psychedelic-assisted therapies globally. “The company has filed a provisional patent application for its pharmaceutical-grade synthetic ibogaine to be used in clinical research and anticipates developing that in conjunction with its software-as-a-service (‘SaaS’) platform iSTRYM,” reads a recent article. iSTRYM is designed to help physicians and patients manage psychiatric medications using smart “digital therapeutics” technology. On August 10, MCURF announced an agreement with Dr. Ken Weingardt to provide consulting services as a senior clinical…

TuesdaySep 14, 2021 2:03 pm

QualityStocksNewsBreaks – Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Recent Acquisition Boosting Psychedelic Drug Development Program

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, announced its most recent acquisition and wholly controlled subsidiary, Adelia Therapeutics Inc., is already reporting success, having achieved certain milestones for the year. Cybin closed on the acquisition of Adelia late last year, with the company noting several key advantages gained through the transaction. According to a recent article, Cybin CEO Doug Drysdale stated that the company sees “this acquisition as potentially advancing Cybin’s ability to innovate our psychedelic drug development program and diversify beyond major depressive disorder. Adelia’s expertise across…

TuesdaySep 14, 2021 1:50 pm

QualityStocksNewsBreaks – Hemptown Organic Corp. Subsidiary Expands Regulation CF Offering to $5M Based on Demand

Hemptown, a privately held British Columbia company, and its subsidiary HT Naturals Inc., have announced an increase of HT Naturals current regulation CF offering; the offering has been increased from $1.07 million to $5 million. According to the announcement, the increase was made as a result of an overwhelming demand from investors and the public. The increase enables interested parties to invest in the opportunity and participate in the current offering of common shares in Hemptown Naturals at $1.40 per share. Committed to providing the highest quality and innovative hemp-derived cannabinoid products, the Hemptown Naturals brand includes premium smokable flowers in…

TuesdaySep 14, 2021 1:24 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Committed to Addressing Major Agri-Food-Tech Industry Challenges

Save Foods (NASDAQ: SVFD) is committed to addressing two major global issues: food waste and loss, as well as food safety. According to the latest study done by World Wildlife Fund (“WWF”) and U.K. retailer Tesco PLC., an estimated 2.5 billion tons of food go uneaten each year. That is an astonishing 1.2 billion tons more than previously reported. “In addition to the astronomical numbers of food wasted, Save Food points out that almost 1 in 10 people fall ill every year from eating contaminated food, costing around $90 billion,” reads a recent article. “Save Foods offers the first green…

TuesdaySep 14, 2021 9:42 am

QualityStocksNewsBreaks – DSG Global Inc. (DSGT) Announces First Production Launch of Imperium-Branded SEV Models

DSG Global (OTCQB: DSGT) today announced that its electric vehicle division, Imperium Motor Company, is commencing its initial production of 682 Imperium-branded Sport Electric Vehicle (“SEV”) models (previously known as the “ET5”). “With the presales deposits pace growing as well as the enthusiasm of our prospective retailers in North America and the imminent completion of the homologation process, we are now in a position to place our first monthly orders for the SEV,” said Christian Dubois, president, Imperium Canada. “We expect this first of three orders of vehicles for the quarter to begin arriving during the fourth quarter and will…

MondaySep 13, 2021 3:27 pm

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Poised to Offer Solution to Rising Challenge Facing Global Health Systems

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more…

MondaySep 13, 2021 3:17 pm

QualityStocksNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Achieves Significant YOY Increases in Revenue, Gross Profits

AmpliTech Group (NASDAQ: AMPG), a state-of-the-art radio frequency (“RF”) signal component developer, has seen growing attention to its IP for satellite and 5G communications networks following its Nasdaq uplisting this year and its more recent inclusion on the Russell Microcap Index. “The company reported growth in its year-over-year and sequential quarterly revenues and gross profits when it released Q2 financial figures for the period ending June 30,” reads a recent article discussing AmpliTech’s performance. “The company also recently reported a Q2 2021 revenue of $1,024,410 signifying a 55% increase from Q2’20 revenue of $660,699. AmpliTech’s gross profits rose 52.5% to…

Site Search

Company Search

Category: QualityStocksNewsBreaks